{"sourcedb":"DevicePMAs@therightstef","sourceid":"P040012_S031","text":"Approval for modifications to the indication statement and instructions for use to incorporate use with the emboshield embolic protection system. the device, as modified, willbe marketed under the trade name rx acculink carotid stem system and is indicated for usein conjunction with abbott vascular's accunet or emboshield family of embolic protectionsystems, for the treatment of patients at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria as previously approved.","project":"consensus_PMA_Age_Indications"}